Table 5 Odds ratios and 95% confidence interval for the association of anaemia and thrombocytosis with clinicopathological characteristics
Variable | Anaemia | Thrombocytosis | ||||
|---|---|---|---|---|---|---|
OR | 95 %CL | P-value | OR | 95 %CL | P-value | |
Age, yr | 0.998 | 0.966–1.031 | 0.893 | 1.008 | 0.970–1.047 | 0.679 |
ASA score (III vs. I–II) | 1.791 | 0.648–4.952 | 0.262 | 0.396 | 0.086–1.826 | 0.235 |
Symptom at presentation | 3.348 | 1.405–7.977 | 0.006 | 7.784 | 1.767–34.298 | 0.007 |
Surgical time, min | 1.005 | 1.002–1.008 | 0.001 | 1.000 | 0.997–1.003 | 0.880 |
Blood loss, ml | 1.000 | 1.000–1.001 | 0.018 | 1.000 | 0.999–1.000 | 0.137 |
Transfusion | 2.734 | 1.374–5.441 | 0.004 | 1.284 | 0.593–2.782 | 0.526 |
Segmental resection of vena cava | 0.465 | 0.199–1.084 | 0.076 | 0.857 | 0.327–2.244 | 0.754 |
Tumour thrombosis level (III–IV vs. 0–II) | 4.750 | 1.910–11.814 | 0.001 | 1.474 | 0.579–3.750 | 0.416 |
Tumour size, cm | 0.988 | 0.883–1.107 | 0.840 | 1.135 | 0.996–1.294 | 0.057 |
Invasion of venous wall | 1.381 | 0.670–2.846 | 0.382 | 0.973 | 0.409–2.311 | 0.950 |
Histologic subtype (non-CCRCC vs. CCRCC) | 2.449 | 0.971–6.175 | 0.058 | 1.677 | 0.621–4.527 | 0.308 |
Nuclear grade (III–IV vs. I–II) | 3.449 | 1.653–7.196 | 0.001 | 2.315 | 0.990–5.412 | 0.053 |
lymph node metastasis | 0.884 | 0.203–3.850 | 0.869 | 0.446 | 0.053–3.758 | 0.458 |
Necrosis | 1.488 | 0.762–2.908 | 0.245 | 1.245 | 0.576–2.689 | 0.577 |